We are live on ! Find out more
X

Xponance Portfolio holdings

AUM $14.1B
1-Year Est. Return 30.11%
This Fund
S&P 500
This Quarter Est. Return
-2.91%
1 Year Est. Return
+30.11%
3 Year Est. Return
+110.39%
5 Year Est. Return
+152.15%
10 Year Est. Return
+370.53%
AUM
$14.1B
AUM Growth
+$741M
Cap. Flow
+$1.58B
Cap. Flow %
11.22%
Top 10 Hldgs %
38.76%
Holding
1,735
New
165
Increased
1,464
Reduced
57
Closed
49

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$110M
2
AAPL icon
Apple
AAPL
+$89M
3
MSFT icon
Microsoft
MSFT
+$81.1M
4
AMZN icon
Amazon
AMZN
+$54.3M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$45.4M

Sector Composition

Rank Sector Weight
1 Technology 35.95%
2 Financials 11.04%
3 Consumer Discretionary 10.63%
4 Communication Services 10.59%
5 Healthcare 9.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VICR icon
1001
Vicor
VICR
$9.91B
$520K ﹤0.01%
+3,230
New +$534K
MSM icon
1002
MSC Industrial Direct
MSM
$7.11B
$520K ﹤0.01%
5,631
+1,248
+28% +$112K
QLYS icon
1003
Qualys
QLYS
$4.94B
$519K ﹤0.01%
5,907
+704
+14% +$78K
LAUR icon
1004
Laureate Education
LAUR
$5.05B
$517K ﹤0.01%
14,852
+1,859
+14% +$63.7K
CROX icon
1005
Crocs
CROX
$6.77B
$517K ﹤0.01%
6,222
+794
+15% +$68K
ALGM icon
1006
Allegro MicroSystems
ALGM
$9.29B
$515K ﹤0.01%
16,337
+3,601
+28% +$124K
BTSG icon
1007
BrightSpring Health Services
BTSG
$13.7B
$515K ﹤0.01%
12,077
+3,252
+37% +$131K
AAOI icon
1008
Applied Optoelectronics
AAOI
$8.87B
$513K ﹤0.01%
+6,065
New +$387K
COGT icon
1009
Cogent Biosciences
COGT
$6.76B
$511K ﹤0.01%
13,289
+2,345
+21% +$86.6K
IRT icon
1010
Independence Realty Trust
IRT
$3.85B
$509K ﹤0.01%
34,199
+4,915
+17% +$80.7K
DOX icon
1011
Amdocs
DOX
$5.44B
$508K ﹤0.01%
7,786
+2,430
+45% +$178K
NVST icon
1012
Envista
NVST
$4.3B
$503K ﹤0.01%
19,822
+4,619
+30% +$120K
CDP icon
1013
COPT Defense Properties
CDP
$4.23B
$502K ﹤0.01%
16,400
+2,313
+16% +$72K
PTCT icon
1014
PTC Therapeutics
PTCT
$6.5B
$502K ﹤0.01%
7,363
+1,191
+19% +$84.3K
UHAL.B icon
1015
U-Haul Holding Co Series N
UHAL.B
$12.3B
$501K ﹤0.01%
11,219
+2,229
+25% +$106K
BMI icon
1016
Badger Meter
BMI
$3.7B
$500K ﹤0.01%
3,283
+285
+10% +$44.7K
THO icon
1017
Thor Industries
THO
$4.04B
$499K ﹤0.01%
6,248
+1,460
+30% +$149K
CVLT icon
1018
Commault Systems
CVLT
$5.81B
$499K ﹤0.01%
6,406
+875
+16% +$83K
ROAD icon
1019
Construction Partners
ROAD
$5.89B
$499K ﹤0.01%
4,488
+743
+20% +$89.1K
NPO icon
1020
Enpro
NPO
$7.07B
$497K ﹤0.01%
1,982
+318
+19% +$79.6K
PIPR icon
1021
Piper Sandler
PIPR
$5.15B
$495K ﹤0.01%
6,466
+938
+17% +$77K
OMF icon
1022
OneMain Financial
OMF
$6.91B
$492K ﹤0.01%
9,207
+1,404
+18% +$83.3K
LIVN icon
1023
LivaNova
LIVN
$4.3B
$492K ﹤0.01%
7,747
+1,098
+17% +$70.8K
XENE icon
1024
Xenon Pharmaceuticals
XENE
$6.4B
$492K ﹤0.01%
8,465
+2,490
+42% +$115K
RNG icon
1025
RingCentral
RNG
$3.16B
$492K ﹤0.01%
13,218
+1,159
+10% +$37.3K

Similar funds

Xponance's Q1 2026 Portfolio in Review

As of Q1 2026, Xponance held 1,735 positions worth $14.1B, up 5.6% from $13.3B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Xponance deployed $1.58B of net new capital in Q1 2026, opening 165 new positions and adding to 1,464 existing holdings. Its largest new stake was Medline Inc: 22,732 shares worth $1.01M.

By sector, the portfolio is most concentrated in Technology at 36% of assets, down from 38% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Principal Financial Group, an estimated $4.8M trimmed.

  • Xponance's largest Q1 2026 buy was Medline Inc: 22,732 shares worth $1.01M.
  • Xponance added most to NVIDIA in Q1 2026, an estimated $110M increase.
  • Xponance's biggest Q1 2026 reduction was Principal Financial Group, cutting an estimated $4.8M.
  • Xponance fully exited Confluent in Q1 2026, selling an estimated $1.34M.
  • Xponance's ten largest holdings make up 39% of its $14.1B portfolio in Q1 2026.
  • Xponance opened 165 new positions and closed 49 in Q1 2026.
  • Xponance's portfolio value rose 5.6% quarter-over-quarter to $14.1B.

Based on Xponance's 13F filing for Q1 2026, filed 13 May 2026.